{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:00:51Z","timestamp":1760295651586,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.biopha.2011.09.007","type":"journal-article","created":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T06:09:21Z","timestamp":1324879761000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of the purinergic system in patients with cervical intraepithelial neoplasia and uterine cancer"],"prefix":"10.1016","volume":"66","author":[{"given":"Paula Acosta","family":"Maldonado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Camera","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Augusto","family":"Negrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Maria","family":"Morsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosa Chitolina","family":"Schetinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2011.09.007_bib0005","first-page":"113","article-title":"Purinergic signaling: pathophysiological roles","volume":"72","author":"Abbracchio","year":"1998","journal-title":"Jpn J Pharmacol"},{"issue":"1","key":"10.1016\/j.biopha.2011.09.007_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7861\/clinmedicine.2-1-45","article-title":"Potential therapeutic targets in the rapidly expanding field of purinergic signaling","volume":"2","author":"Burnstock","year":"2002","journal-title":"Clin Med"},{"key":"10.1016\/j.biopha.2011.09.007_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signaling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopha.2011.09.007_bib0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.bjp.0706429","article-title":"Purinergic signalling","volume":"147","author":"Burnstock","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.biopha.2011.09.007_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/biof.5520310205","article-title":"NTPDase and 5\u2032nucleotidase activities in physiological and disease conditions: new perspectives for human health","volume":"31","author":"Schetinger","year":"2007","journal-title":"Biofactors"},{"key":"10.1016\/j.biopha.2011.09.007_bib0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","article-title":"The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance","volume":"2","author":"Robson","year":"2006","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.biopha.2011.09.007_bib0035","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bjp.0702690","article-title":"Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5\u2032-diphosphate (ADP) in human platelets","volume":"127","author":"Park","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopha.2011.09.007_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-0102(92)90030-G","article-title":"Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells","volume":"13","author":"Rathbone","year":"1992","journal-title":"Neurosci Res"},{"key":"10.1016\/j.biopha.2011.09.007_bib0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0163-7258(00)00053-X","article-title":"Tumor promoting functions of adenosine","volume":"87","author":"Spychala","year":"2000","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.biopha.2011.09.007_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: an endogenous regulator of innate immunity","volume":"25","author":"Hask\u00f3","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.biopha.2011.09.007_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2009.05.005","article-title":"An endogenous modulator of innate immune system with therapeutic potential","volume":"616","author":"Vijay","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopha.2011.09.007_bib0060","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/j.1538-7836.2003.00479.x","article-title":"Heterologous cell\u2013cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1)","volume":"1","author":"Marcus","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.biopha.2011.09.007_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ddr.1097","article-title":"Ectonucleotidases: some recent developments and a note on nomenclature","volume":"52","author":"Zimmermann","year":"2001","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.biopha.2011.09.007_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4439(03)00058-9","article-title":"Physiological and patophysiological functions of the ecto-nucleotide pyrophosphatase\/phosphodiesterase family","volume":"1638","author":"Goding","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biopha.2011.09.007_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0301-0082(97)00013-0","article-title":"Cell surface adenosine deaminase: much more than an ectoenzyme","volume":"52","author":"Franco","year":"1997","journal-title":"Progre Neurobiol"},{"key":"10.1016\/j.biopha.2011.09.007_bib0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide and nucleoside-converting ectoenzymes: important modulators of purinergic signaling cascade","volume":"1783","author":"Yegutkin","year":"2008","journal-title":"Biochim Biophis Acta"},{"key":"10.1016\/j.biopha.2011.09.007_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(03)00117-3","article-title":"Inherited bleeding disorders: disorders of platelet adhesion and aggregation","volume":"49","author":"Ramasamy","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.biopha.2011.09.007_bib0090","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ed","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.biopha.2011.09.007_bib0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.mpaic.2010.02.015","article-title":"Haemostasis, blood platelets and coagulation","volume":"11","author":"Eyre","year":"2010","journal-title":"Anesthesia Int Care Med"},{"key":"10.1016\/j.biopha.2011.09.007_bib0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3322\/canjclin.51.2.92","article-title":"Cervical cancer: prevention, diagnosis and therapeutics","volume":"251","author":"Janicek","year":"2001","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.biopha.2011.09.007_bib0105","unstructured":"An introduction to cervical intraepithelial neoplasia (CIN), assessed on 22\/11\/2006, available on www.iarc.fr."},{"key":"10.1016\/j.biopha.2011.09.007_bib0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cca.2005.09.025","article-title":"Oxidative status in patients submitted to conization and radiation treatments for uterine cervix neoplasia","volume":"366","author":"Maldonado","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.biopha.2011.09.007_bib0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clinbiochem.2007.12.019","article-title":"Ectonucleotide Pyrophosphatase\/Phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in patients with uterine cervix neoplasia","volume":"41","author":"Maldonado","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.biopha.2011.09.007_bib0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.biopha.2010.02.007","article-title":"Nucleotide degrading enzymes in platelets from uterine cervical neoplasia patients treated with conization or radiotherapy","volume":"64","author":"Maldonado","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.biopha.2011.09.007_bib0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/09537109609023582","article-title":"ATP diphosphohydrolase activity (Apyrase E.C.3.1.5.) in human blood platelets","volume":"7","author":"Pilla","year":"1996","journal-title":"Platelets"},{"key":"10.1016\/j.biopha.2011.09.007_bib0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0003-2697(86)90640-8","article-title":"A direct colorimetric assay for Ca2+-ATPase activity","volume":"157","author":"Chan","year":"1986","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biopha.2011.09.007_bib0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/09537100500246641","article-title":"Ecto-nucleotide pyrophosphatase\/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties","volume":"17","author":"Furstenau","year":"2006","journal-title":"Platelets"},{"key":"10.1016\/j.biopha.2011.09.007_bib0140","series-title":"Methods of enzymatic analysis","article-title":"Colorimetric method","author":"Guisti","year":"1984"},{"key":"10.1016\/j.biopha.2011.09.007_bib0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"3","key":"10.1016\/j.biopha.2011.09.007_bib0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbadis.2004.11.001","article-title":"Enzymes that hydrolyze adenine nucleotides in platelets from breast cancer patients","volume":"1740","author":"Ara\u00fajo","year":"2005","journal-title":"Biochim Biophis Acta"},{"issue":"7\u20138","key":"10.1016\/j.biopha.2011.09.007_bib0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinbiochem.2008.01.027","article-title":"Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients","volume":"41","author":"Battisti","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.biopha.2011.09.007_bib0200","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopha.2011.06.003","article-title":"Oxidative stress and antioxidant status in prostate cancer patients: relation to gleason score,treatment and bone metastasis","volume":"65","author":"Battisti","year":"2011","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.biopha.2011.09.007_bib0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000046583","article-title":"Epidemiology of thrombosis in cancer","volume":"106","author":"Rickles","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.biopha.2011.09.007_bib0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000046585","article-title":"Pathogenetic mechanisms of thrombosis in malignancy","volume":"106","author":"Donati","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.biopha.2011.09.007_bib0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046592","article-title":"Thromboprophylaxis in the cancer patient","volume":"106","author":"Thodiyil","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.biopha.2011.09.007_bib0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1063-5823(03)01013-5","article-title":"ATP in the treatment of advanced cancer","volume":"54","author":"Abraham","year":"2003","journal-title":"Curr Top Membr"},{"key":"10.1016\/j.biopha.2011.09.007_bib0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.arcmed.2009.10.012","article-title":"Diagnostic value of adenosine deaminase activity in benign and malignant breast tumors","volume":"41","author":"Aghaei","year":"2010","journal-title":"Arch Med Res"},{"issue":"2","key":"10.1016\/j.biopha.2011.09.007_bib0185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.biopha.2011.09.007_bib0190","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1586\/14737140.8.8.1247","article-title":"The role of platelet activation in tumor metastasis","volume":"8","author":"Borsig","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.biopha.2011.09.007_bib0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12253-008-9071-7","article-title":"Extracellular ATP and cancer\u00a0\u2013\u00a0an overview as especial reference to P2 purinergic receptors","volume":"14","author":"Deli","year":"2008","journal-title":"Pathol Oncol Research"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332211001661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332211001661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:48:42Z","timestamp":1760093322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332211001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0753332211001661"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2011.09.007","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the purinergic system in patients with cervical intraepithelial neoplasia and uterine cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2011.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}